Agilent Technologies, Inc. $A Shares Sold by Arizona State Retirement System

Arizona State Retirement System lowered its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 7.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 77,796 shares of the medical research company’s stock after selling 6,132 shares during the quarter. Arizona State Retirement System’s holdings in Agilent Technologies were worth $10,586,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in A. Massachusetts Financial Services Co. MA grew its position in shares of Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC grew its position in shares of Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after buying an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. grew its position in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after buying an additional 1,340,161 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Agilent Technologies by 3,091.1% during the fourth quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock worth $109,974,000 after buying an additional 782,888 shares in the last quarter. Finally, Lazard Asset Management LLC grew its position in shares of Agilent Technologies by 639.4% during the second quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock worth $80,093,000 after buying an additional 586,931 shares in the last quarter.

Analyst Ratings Changes

A has been the subject of a number of recent analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Barclays decreased their price target on shares of Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $155.00 to $160.00 in a report on Monday, January 5th. HSBC started coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 price objective for the company. Finally, Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating for the company in a report on Thursday, February 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $163.71.

Agilent Technologies Stock Performance

Agilent Technologies stock opened at $115.60 on Friday. The company has a market cap of $32.67 billion, a PE ratio of 25.52, a P/E/G ratio of 2.41 and a beta of 1.30. The company has a fifty day moving average price of $117.25 and a two-hundred day moving average price of $133.18. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. Agilent Technologies, Inc. has a 12 month low of $104.10 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). The business had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts expect that Agilent Technologies, Inc. will post 5.95 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were issued a dividend of $0.255 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s payout ratio is 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.